BioCentury
ARTICLE | Clinical News

Gamma interferon: CNCT began Phase II trials

January 27, 1997 8:00 AM UTC

Connective Therapeutics Inc. (CNCT), Palo Alto, Calif. Product: Gamma interferon Indication: Keloids Status: CNCT began Phase II trials in keloids, fibrotic growths that result from excessive collage...